What is the role of transplant in treatment of multiple myeloma? From our town meeting in Little Rock, Arkansas, in…
Browsing: Acute Lymphoblastic Leukemia
What are the benefits to participating in multiple myeloma clinical trials? Dr. Faith Davies of UAMS Myeloma Institute responds to…
Will my essential thrombocythemia (ET) or polycythemia vera (PV) progress to myelofibrosis (MF)? Patient Power host and MF patient, Andrew…
Toni Choueiri, MD of the Dana-Farber Cancer Center, Boston, MA discusses the Phase III METEOR randomized clinical trial of cabozantinib…
Neal Shore, MD of the Carolina Urologic Research Center, Myrtle Beach, SC, discusses the advances in the development of treatments…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, discusses the Phase II safety study CheckMate…
Jonathan Ledermann, MD, FRCP from University College London, London, UK discusses his presentation on the update on the results of…
Hendrik-Tobias Arkenau, MD, PhD from the Sarah Cannon Research Institute, London, UK discusses his highlights from the American Society of…
David Ross Camidge, MD, PhD of the University of Colorado, Denver, CO, provides an insight into the study (NCT01631552) of…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK discusses the use of the new immunotherapy…
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the BGJ398 clinical trial in patients with previously treated advanced/metastatic…
Erika Hamilton of Sarah Cannon Research Institute, Nashville, TN talks about the Phase I trial of AZD2014 for the treatment…
Bristol-Myers Squibb Company announced that CheckMate 026, a trial investigating the use of Opdivo or nivolumab as monotherapy, did not…
Jalid Sehouli, MD, PhD from Charité Comprehensive Cancer Center, Berlin, Germany discusses the Phase II TRIAS 2009 trial of sorafenib…
Grant McArthur, MBBS, BMedSci, PhD, FRACP from the Peter MacCallum Cancer Centre, Melbourne, Australia gives an overview of mutations in…
Grant McArthur, MBBS, BMedSci, PhD, FRACP from the Peter MacCallum Cancer Centre, Melbourne, Australia discusses the results of the Phase…
Gary K. Schwartz, MD of the Columbia University Medical Center, New York, NY discusses the success and potential of immunology…
Manmeet Ahluwalia, MD of the Cleveland Clinic Cancer Center discusses how ANG1005 shows promise for patients with leptomenigeal disease
Manmeet Ahluwalia, MD from Cleveland Clinic Cancer Center and the Predictive and Prognostic biomarkers for Brain Metastasis
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses the side effect profile of ANG1005 from ASCO 2016
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center outlines how ANG1005 shows promise in Brain Cancer at ASCO 2016
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Blood Brain Barrier and TKI in Brain Cancer treatment at ASCO…
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Treating Brain Metastasis is being redefined due to genomic profiling from…
Jame Abraham, MD discusses PD-L1 in Triple Negative Breast Cancer from ASCO 2016
Jame Abraham, MD @CleClinicMD Cleveland Clinic Cancer Center highlights the Current and future Immunotherapy outlook in breast cancer from ASCO…
Dr. Jame Abraham, MD of the Cleveland Clinic Cancer Center @CleClinicMD discusses the PALOMA trials summary and Palbociclib in ER-positive…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. George Hanna discusses which esophageal cancer patients…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David Cunningham discusses which esophageal cancer patients…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Margaret A. Tempero discusses new agents and…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Massimo Falconi examines whether or not we…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Thomas Seufferlein argues that it is not…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Jordan D. Berlin argues that it is…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Pascal Hammel discusses screening in familial pancreatic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Dileep Lobo examines whether peri-operative nutritional support…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Florian Strasser discusses cachexia and sarcopenia in…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Jens Ricke discusses the pitfalls in imaging…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy discusses the back and forth between basic research and clinical…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy provides an overview of the results of the Phase III…
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses new treatments for elderly acute myeloid…
Nearly 12% of men with advanced prostate cancer have inherited mutations in genes that play a role in repairing damaged…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses the BISCAY clinical trial in bladder cancer (NCT02546661). The…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France discusses the current medical need of Philadelphia chromosome-positive (Ph+)…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses a talk on immune checkpoint inhibitors in bladder cancer…
Joseph Mikhael, MD from the Mayo Clinic, Scottsdale, AZ discusses his highlights for multiple myeloma (MM) from the American Society…
Anton Hagenbeek, MD, PhD from University of Amsterdam, Netherlands provides a summary of the press briefings held at the European…
John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA discusses highlights for chronic lymphocytic leukemia (CLL) from the…
John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA provides an overview of an educational session on the…
Finbarr Cotter, MD, PhD from British Society of Hematology (BSH) Conferences and Barts Health NHS Trust, UK discussing the 2016…
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY discusses the mechanism of action of ibrutinib and…